VENTYX BIOSCIENCES INC. - COMMON STOCK

Ventyx Biosciences to Participate in the Barclays Global Healthcare Conference

07 3 2022 08:00:01 提供 Nasdaq GlobeNewswire

Ventyx Biosciences Announces First Patient Dosed in a Phase 2 Clinical Trial of VTX002 for the Treatment of Moderate-to-Severe Ulcerative Colitis

06 12 2021 08:00:01 提供 Nasdaq GlobeNewswire

Ventyx Biosciences to Participate in Two Upcoming Investor Conferences

19 11 2021 08:00:00 提供 Nasdaq GlobeNewswire

Ventyx Biosciences Reports Third Quarter Financial Results and Provides Business Update

17 11 2021 16:11:04 提供 Nasdaq GlobeNewswire

Ventyx Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

25 10 2021 16:58:33 提供 Nasdaq GlobeNewswire

Ventyx Biosciences Announces Pricing of Upsized Initial Public Offering

20 10 2021 20:38:40 提供 Nasdaq GlobeNewswire